[1]
Safnurbaiti, D.P., Andayani, T.M. and Irijanto, F. 2018. Cost Analysis and Value of Utility for Patients in Haemodialysis with Carbonic Cevelamer Therapy. Oceana Biomedicina Journal. 1, 2 (Jul. 2018), 79–89. DOI:https://doi.org/10.30649/obj.v1i2.12.